methotrexate
Olokizumab has potential for tough-to-treat rheumatoid arthritis
Active moderate-to-severe rheumatoid arthritis that has responded inadequately to a commonly used therapy could soon be treated with olokizumab, researchers report at the 2015 American College of Rheumatology Annual Meeting. Continue reading
Methotrexate: injection may be better than oral treatment for early rheumatoid arthritis, research group claims
People who take methotrexate by mouth for rheumatoid arthritis could see better results using a subcutaneous version of the drug, according to research in the Annals of the Rheumatic Diseases.
A total of 666 people from Canada and the US were enrolled in the study which aimed to assess the difference in outcome of oral versus subcutaneous methotrexate as an initial therapy for people with early rheumatoid arthritis. Continue reading
2024 ISSUE 4
